Mortality associated with antiarrhythmic medication for atrial fibrillation among patients with left ventricular hypertrophy.
Arianne Clare AgdamagAnders WestanmoAmy GravelyNatthapon AngsubhakornLin Yee ChenSelçuk AdabagPublished in: Pacing and clinical electrophysiology : PACE (2023)
Among patients with AF and LVH, amiodarone was associated with a significantly higher mortality risk than other AAM.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left ventricular
- heart failure
- oral anticoagulants
- left atrial appendage
- cardiovascular events
- direct oral anticoagulants
- acute myocardial infarction
- hypertrophic cardiomyopathy
- aortic stenosis
- cardiac resynchronization therapy
- healthcare
- mitral valve
- risk factors
- percutaneous coronary intervention
- adverse drug
- type diabetes
- emergency department
- ejection fraction
- venous thromboembolism
- transcatheter aortic valve replacement
- aortic valve